Dr Reddy's launches Supanac

Dr Reddy's Laboratories Limited, has launched Supanac (Diclofenac potassium immediate release 50 mg tablets), in India, increasing its product offering in the non-steroidal anti-inflammatory drugs (NSAID) market. Leading brands of Dr Reddy's in this segment are Nise and Retoz.

The market for NSAID products is currently pegged at $688 million (Rs 2,700 crore) and is growing at 20 per cent annually. Diclofenac has been marketed in India for more than 15 years and it widely used for acute pain management.